These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 11015089

  • 1. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
    Weese JL, Harbison SP, Stiller GD, Henry DH, Fisher SA.
    Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
    [Abstract] [Full Text] [Related]

  • 2. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
    Fu S, Lu JJ, Zhang Q, Yang Z, Peng L, Xiong F.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1488-94. PubMed ID: 18538489
    [Abstract] [Full Text] [Related]

  • 3. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gonen M, Kelsen DP, Brennan MF, Coit DG.
    Ann Surg Oncol; 2007 Dec 01; 14(12):3412-8. PubMed ID: 17909917
    [Abstract] [Full Text] [Related]

  • 4. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ, Newman E, Iqbal S, Chang RY, Potmesil M, Ryan T, Donahue B, Chandra A, Liu M, Utate M, Hiotis S, Pachter LH, Hochster H, Muggia F.
    Ann Surg Oncol; 2012 Feb 01; 19(2):478-85. PubMed ID: 21769462
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
    Ajani JA, Mansfield PF, Janjan N, Morris J, Pisters PW, Lynch PM, Feig B, Myerson R, Nivers R, Cohen DS, Gunderson LL.
    J Clin Oncol; 2004 Jul 15; 22(14):2774-80. PubMed ID: 15254045
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M, Shiozaki H, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Tsujinaka T, Monden M.
    World J Surg; 2002 Sep 15; 26(9):1155-9. PubMed ID: 12209246
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial.
    Allal AS, Zwahlen D, Bründler MA, de Peyer R, Morel P, Huber O, Roth AD.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1286-9. PubMed ID: 16137836
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC.
    J Surg Oncol; 2007 May 01; 95(6):461-8. PubMed ID: 17192913
    [Abstract] [Full Text] [Related]

  • 13. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
    Schuhmacher CP, Fink U, Becker K, Busch R, Dittler HJ, Mueller J, Siewert JR.
    Cancer; 2001 Mar 01; 91(5):918-27. PubMed ID: 11251943
    [Abstract] [Full Text] [Related]

  • 15. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M, Coit D, Brennan M, Qin LX, Gonen M, Klimstra D, Tang L, Kelsen DP, Shah MA.
    Am J Clin Oncol; 2009 Aug 01; 32(4):356-62. PubMed ID: 19381079
    [Abstract] [Full Text] [Related]

  • 16. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
    Peracchia A, Bonavina L, Via A, Incarbone R.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):289-94. PubMed ID: 10606171
    [Abstract] [Full Text] [Related]

  • 17. Role of post-operative chemoradiation in resected gastric cancer.
    Macdonald JS.
    J Surg Oncol; 2005 Jun 01; 90(3):166-70. PubMed ID: 15895449
    [Abstract] [Full Text] [Related]

  • 18. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Jun 01; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 19. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.
    Ann Surg Oncol; 2011 Dec 01; 18(13):3743-54. PubMed ID: 21556952
    [Abstract] [Full Text] [Related]

  • 20. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.